BioTecNika - May 2015

BioTecNika - May 2015

Magzter GOLDã§èªã¿æŸé¡ãå©çšãã
1 åã®è³Œèªã§ BioTecNika ãš 9,000 ããã³ãã®ä»ã®éèªãæ°èãèªãããšãã§ããŸã  ã«ã¿ãã°ãèŠã
1 ã¶æ $14.99
1 幎$149.99
$12/ã¶æ
ã®ã¿è³Œèªãã BioTecNika
ãã®å·ãè³Œå ¥ $0.99
Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.
ãã®åé¡ã§
The Indian biotech sector faced a major turn of events when Daiichi Sankyo, Japanese firm whose hide and seek with Indian drug company Ranbaxy came to an end as it decided to sell off its entire holding of Sun Pharmaceutical Industries and exit Indian pharma sector after a struggle of eight years. Why it had to offload Ranbaxy and what is in store with the companyâs future businesses, find out in Biotecnika magazineâs May 2015 issue. Other stories to keep readerâs interest intact are âIndia succumbs to H1N1â, âAre we amid biotech bubbleâ, âIs it time to kill your R&D project?â and much more. Biotecnika bureau had a chance to interact with Ms. Anu Acharya, CEO, Mapmygenome on her entrepreneurial voyage and Dr. Anurag Mathur, Lead author, âHeart-on-chipâ on his recent research. Grab your copy to find out what they had to say!
BioTecNika Magazine Description:
åºç瀟: Biotecnika Info Labs Pvt Ltd
ã«ããŽãªãŒ: Education
èšèª: English
çºè¡é »åºŠ: Monthly
The essential guide to all the news in biotechnology industry & Academia run by India's Most popular Biotechnology Portal www.biotecnika.org. BioTecNika has access to worldâs most influential Biotech entrepreneurs, Businesses and institutions. The magazine showcases all this via exclusive features that are insightful, informative and presented with style.
Distinguished by its indepth analysis and latest information, BioTecNika has been an indispensable part of life of Biotechies for over 8+ years. Our well-heeled readership shape opinions and trends in India and across the region. This affluent and influential group is almost impossible to reach - except through the pages of BioTecNika
ãã€ã§ããã£ã³ã»ã«OK [ å¥çŽäžèŠ ]
ããžã¿ã«ã®ã¿